Tecan Group AG is a leading pharmaceutical company based in Switzerland with a low-risk ESG score of 12.1. Specializing in automated laboratory instruments and solutions for diagnostics and life sciences research markets, Tecan operates in two segments. The Life Sciences Business segment supplies end users with automated workflow solutions, while the Partnering Business segment develops and manufactures OEM instruments and components. With a majority of revenue generated in the Americas and Europe, Tecan Group AG is a significant player in the pharmaceutical industry.